Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma

BACKGROUND AND OBJECTIVE: A quantitative tumor response evaluation to molecular-targeting agents in advanced renal cell carcinoma (RCC) is debatable. We aimed to evaluate the relationship between radiologic tumor response and pathological response in patients with advanced RCC who underwent presurgi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Hosogoe, Shogo, Hatakeyama, Shingo, Kusaka, Ayumu, Hamano, Itsuto, Tanaka, Yoshimi, Hagiwara, Kazuhisa, Hirai, Hideaki, Morohashi, Satoko, Kijima, Hiroshi, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Ohyama, Chikara
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564804/
https://ncbi.nlm.nih.gov/pubmed/28572534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17930
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi